SCTMB1 |
Family History of Congenital Immunodeficiency |
Active |
|
SCTMB2 |
Consent Documented Elsewhere |
Active |
|
SCTMB3 |
Legal Decision Maker |
Active |
|
SCTMB4 |
Immunity due to immunization |
Active |
|
SCTMB5 |
Severely immunocompromised |
Active |
|
SCTMB6 |
History of intussusception |
Active |
|
SCTMB7 |
History of vasovagal syncope |
Active |
|
SCTMB8 |
Rabies pre-exposure vaccination |
Active |
|
SCTMB9 |
Rabies post-exposure vaccination |
Active |
|
SCTMB10 |
Candidiasis (bronchi, trachea or lungs) |
Active |
|
SCTMB11 |
CD4+ T-lymphocyte count of < 200 cells/μL |
Active |
|
SCTMB12 |
CD4+ T-lymphocyte percentage of total lymphocytes of < 14 |
Active |
|
SCTMB13 |
Cervical cancer (invasive) |
Active |
|
SCTMB14 |
Cytomegalovirus diseases (other than in liver, spleen or nodes) |
Active |
|
SCTMB15 |
Herpes simplex: chronic ulcer(s) (> one month duration) or bronchitis, pneumonitis or esophagitis) |
Active |
|
SCTMB16 |
Mycobacterium of other species or unidentified species (disseminated or extrapulmonary) |
Active |
|
SCTMB17 |
Immigration Medical Examination |
Active |
|
SCTMB18 |
Chancre |
Active |
|
SCTMB19 |
Cough with whoop |
Active |
|
SCTMB20 |
Genital growth |
Active |
|
SCTMB21 |
Genital ulcer |
Active |
|
SCTMB22 |
Pseudomembrane on airways |
Active |
|
SCTMB23 |
Symptoms associated with site of disease |
Active |
|
SCTMB24 |
Unexplained hemorrhage |
Active |
|
SCTMB25 |
Weak, slow pulse (faget sign) |
Active |
|
SCTMB26 |
Lymph node drainage, suppuration |
Active |
|
SCTMB27 |
Insurance company report |
Active |
|
SCTMB28 |
Organ/tissue donor report |
Active |
|
SCTMB29 |
Out-of-Province or Out-of-Country notification |
Active |
|
SCTMB30 |
Self reported |
Active |
|
SCTMB31 |
Beef consumption in UK 1980-90 |
Active |
|
SCTMB32 |
Blunt trauma, burn or non-penetrating injury |
Active |
|
SCTMB33 |
Body piercing, scarification, tatoo application |
Active |
|
SCTMB34 |
Born in/ Immigrated from HIV-endemic country |
Active |
|
SCTMB35 |
Casual and anonymous sex partners |
Active |
|
SCTMB36 |
Child of hepatitis B -positive mother |
Active |
|
SCTMB37 |
Child of hepatitis C -positive mother |
Active |
|
SCTMB38 |
Child of HIV positive mother |
Active |
|
SCTMB39 |
Chronic cerebrospinal fluid leak |
Active |
|
SCTMB40 |
Chronic pain treatment |
Active |
|
SCTMB41 |
Complement factor D deficiency |
Active |
|
SCTMB42 |
Concurrent or recent infection |
Active |
|
SCTMB43 |
Has/had visitors from endemic country |
Active |
|
SCTMB44 |
History of Hepatitis C |
Active |
|
SCTMB45 |
History of incarceration |
Active |
|
SCTMB46 |
History of residence in an endemic country |
Active |
|
SCTMB47 |
Injection drug use outside Canada |
Active |
|
SCTMB48 |
Lack of access to treated running water |
Active |
|
SCTMB49 |
Long term (> 1 month) corticosteroid use (prednisone > = 15mg/day or equivalent) |
Active |
|
SCTMB50 |
Men who have sex with men |
Active |
|
SCTMB51 |
Acupuncture |
Active |
|
SCTMB52 |
History of Blood Transfusion/Donation |
Active |
|
SCTMB53 |
New sex partner |
Active |
|
SCTMB54 |
Other activities involving skin punctures |
Active |
|
SCTMB55 |
Other chronic medical conditions |
Active |
|
SCTMB56 |
Partner has other sex partners |
Active |
|
SCTMB57 |
Poor ventilation/air quality |
Active |
|
SCTMB58 |
Previous anti retro-viral therapy |
Active |
|
SCTMB59 |
Recent Immigration (in last 5 years) |
Active |
|
SCTMB60 |
Recipient of blood/ blood products outside of Canada |
Active |
|
SCTMB61 |
Reports contact to a new or previously diagnosed case |
Active |
|
SCTMB62 |
Sex outside Canada (country) |
Active |
|
SCTMB63 |
Sex with known / suspected HIV positive person |
Active |
|
SCTMB64 |
Sex with person from HIV-endemic country |
Active |
|
SCTMB65 |
Sex with person who uses injection drugs |
Active |
|
SCTMB66 |
Shared injection equipment |
Active |
|
SCTMB67 |
Street-involved, gang involved |
Active |
|
SCTMB68 |
Substance use during last sexual exposure |
Active |
|
SCTMB69 |
Transplant related immunosuppression |
Active |
|
SCTMB70 |
Travel to endemic area/region |
Active |
|
SCTMB71 |
Travel to endemic country |
Active |
|
SCTMB72 |
Tumor necrosis factor alpha inhibitors |
Active |
|
SCTMB73 |
Use of Internet websites, applications for meeting sexual partners |
Active |
|
SCTMB74 |
Fibronodular disease on chest x-ray |
Active |
|
SCTMB75 |
Mental Health Issue (underlying) |
Active |
|
SCTMB76 |
Neonate – High risk for Hep-B |
Active |
|
SCTMB77 |
Low Birth Weight – Under 2000 grams |
Active |
|
SCTMB78 |
Social Determinants of Health |
Active |
|
SCTMB79 |
History of Exposure |
Active |
|
SCTMB80 |
Medical |
Active |
|
SCTMB81 |
Social Behavioural |
Active |
|
SCTMB82 |
Special Populations |
Active |
|
SCTMB83 |
Immunization |
Active |
|
SCTMB84 |
Immunizations Up to Date/Complete |
Active |
|
SCTMB85 |
Perinatal |
Active |
|
SCTMB86 |
Vehicle |
Active |
|
SCTMB87 |
Received blood or blood products |
Active |
|
SCTMB88 |
Donated blood or blood products |
Active |
|
SCTMB89 |
Tattoo, body piercing, scarification |
Active |
|
SCTMB90 |
Other exposure to infected blood or blood products |
Active |
|
SCTMB91 |
Blood - mucous membranes |
Active |
|
SCTMB92 |
Oral-genital |
Active |
|
SCTMB93 |
Oral-rectal |
Active |
|
SCTMB94 |
Genital-genital |
Active |
|
SCTMB95 |
Genital-rectal |
Active |
|
SCTMB96 |
Same sex |
Active |
|
SCTMB97 |
Heterosexual sex |
Active |
|
SCTMB98 |
Receptive anal sex |
Active |
|
SCTMB99 |
Insertive anal sex |
Active |
|
SCTMB100 |
Bisexual partner |
Active |
|
SCTMB101 |
IDU partner |
Active |
|
SCTMB102 |
Partner from endemic country |
Active |
|
SCTMB103 |
Partner is previously diagnosed case |
Active |
|
SCTMB104 |
Flies |
Active |
|
SCTMB105 |
Recreational - lakes/rivers |
Active |
|
SCTMB106 |
Recreational - swimming pool/hot tub |
Active |
|
SCTMB107 |
Drinking water - municipal/community water system |
Active |
|
SCTMB108 |
Drinking water - private source |
Active |
|
SCTMB109 |
Drinking water - bottled |
Active |
|
SCTMB110 |
Treated water |
Active |
|
SCTMB111 |
Untreated water |
Active |
|
SCTMB112 |
Lick |
Active |
|
SCTMB113 |
In same room |
Active |
|
SCTMB114 |
Domestic pet |
Active |
|
SCTMB115 |
Wild animal |
Active |
|
SCTMB116 |
Stray animal |
Active |
|
SCTMB117 |
Handling/exposure of animal excretia |
Active |
|
SCTMB118 |
Community contact |
Active |
|
SCTMB119 |
Facility non-recreational |
Active |
|
SCTMB120 |
Multiple settings |
Active |
|
SCTMB121 |
Private function |
Active |
|
SCTMB122 |
Congregate/communal living setting |
Active |
|
SCTMB123 |
Animal processing plant |
Active |
|
SCTMB124 |
Bathhouse |
Active |
|
SCTMB125 |
Cafeteria |
Active |
|
SCTMB126 |
Close non-household contacts |
Active |
|
SCTMB127 |
Commercial prepared event |
Active |
|
SCTMB128 |
Community centre/arena |
Active |
|
SCTMB129 |
Community prepared event |
Active |
|
SCTMB130 |
Convention centre |
Active |
|
SCTMB131 |
Correctional facility – federal |
Active |
|
SCTMB132 |
Correctional facility – provincial |
Active |
|
SCTMB133 |
Dormitory |
Active |
|
SCTMB134 |
Farm – direct to consumer (farmer’s market, farm to table) |
Active |
|
SCTMB135 |
Festival/fair/mass gathering |
Active |
|
SCTMB136 |
Group home |
Active |
|
SCTMB137 |
Home prepared |
Active |
|
SCTMB138 |
Hot tub |
Active |
|
SCTMB139 |
Hotel/motel |
Active |
|
SCTMB140 |
House party |
Active |
|
SCTMB141 |
Household contacts |
Active |
|
SCTMB142 |
Mobile canteen |
Active |
|
SCTMB143 |
Did Not Travel |
Active |
|
SCTMB144 |
Outside of Canada/United States |
Active |
|
SCTMB145 |
Petting zoo |
Active |
|
SCTMB146 |
Primary/secondary school |
Active |
|
SCTMB147 |
River/lake/ocean |
Active |
|
SCTMB148 |
Shelter |
Active |
|
SCTMB149 |
Short term residential facility |
Active |
|
SCTMB150 |
Spa |
Active |
|
SCTMB151 |
Splash pad/wading pool |
Active |
|
SCTMB152 |
Swimming pool/water park |
Active |
|
SCTMB153 |
Vending machine |
Active |
|
SCTMB154 |
Veterinary clinic |
Active |
|
SCTMB155 |
Visiting friends and relatives |
Active |
|
SCTMB156 |
Widespread community contact |
Active |
|
SCTMB157 |
Travel within Canada |
Active |
|
SCTMB158 |
Travel within home province/territory |
Active |
|
SCTMB159 |
Travel within United States of America |
Active |
|
SCTMB160 |
Respiratory TB, other, lab confirmed |
Active |
|
SCTMB161 |
Lung TB, culture negative |
Active |
|
SCTMB162 |
Lung TB, specimen not done |
Active |
|
SCTMB163 |
Intrathoracic lymph node TB, not lab confirmed |
Active |
|
SCTMB164 |
Larynx, trachea and bronchus TB, not lab confirmed |
Active |
|
SCTMB165 |
Pleurisy TB, not lab confirmed |
Active |
|
SCTMB166 |
Primary Respiratory TB, not lab confirmed |
Active |
|
SCTMB167 |
Respiratory TB, other, not lab confirmed |
Active |
|
SCTMB168 |
Nervous system TB, other |
Active |
|
SCTMB169 |
Other specified organ TB |
Active |
|
SCTMB170 |
Miliary tuberculosis, single site |
Active |
|
SCTMB171 |
Miliary tuberculosis, other |
Active |
|
SCTMB172 |
Influenza Intramuscular Vaccine |
Active |
|
SCTMB173 |
Poor hand hygiene |
Active |
|
SCTMB174 |
Unsafe food handling |
Active |
|
SCTMB175 |
Does not clean home |
Active |
|
SCTMB176 |
Candidiasis of the bronchi, trachea, or lungs |
Active |
|
SCTMB177 |
Hydrophobia |
Active |
|
SCTMB178 |
Ocular involvement (Iritis and Keratitis) |
Active |
|
SCTMB179 |
Peritonitis or Intestinal perforation |
Active |
|
SCTMB180 |
Testicular pain/tenderness/swelling |
Active |
|
SCTMB181 |
Influenza high-dose vaccine |
Active |
|
SCTMB182 |
Envelope |
Active |
|
SCTMB183 |
Envelope, opened |
Active |
|
SCTMB184 |
Envelope, unopened |
Active |
|
SCTMB185 |
Litter, avian |
Active |
|
SCTMB186 |
Stool specimen with sodium acetate formalin (SAF) preservative |
Active |
|
SCTMB187 |
Biohazard Detection System cartridge |
Active |
|
SCTMB188 |
Lung TB, sputum smear neg & culture pending |
Active |
|
SCTMB189 |
Born to infected mother |
Active |
|
SCTMB190 |
Condom use - Anal sex |
Active |
|
SCTMB191 |
Condom use - Oral sex |
Active |
|
SCTMB192 |
Condom use - Vaginal sex |
Active |
|
SCTMB193 |
Exposure meeting setting/location: Other community in Manitoba |
Active |
|
SCTMB194 |
Exposure meeting setting/location: Other province in Canada |
Active |
|
SCTMB195 |
Exposure meeting setting/location: Outdoors |
Active |
|
SCTMB196 |
Exposure meeting setting/location: Outside Canada |
Active |
|
SCTMB197 |
Previous treatment for syphilis |
Active |
|
SCTMB198 |
Alcohol use during sexual exposure |
Active |
|
SCTMB199 |
Non-alcohol use during sexual exposure |
Active |
|
SCTMB200 |
Injection drug use during sexual exposure |
Active |
|
SCTMB201 |
Non-injection drug use during sexual exposure |
Active |
|
SCTMB202 |
New sex partner in period of communicability |
Active |
|
SCTMB203 |
Has given goods in exchange for sex |
Active |
|
SCTMB204 |
Has received goods in exchange for sex |
Active |
|
SCTMB205 |
North American Indigenous |
Active |
|
SCTMB206 |
Western European |
Active |
|
SCTMB207 |
Other European |
Active |
|
SCTMB208 |
Other African |
Active |
|
SCTMB209 |
South Asian |
Active |
|
SCTMB210 |
East and South East Asian |
Active |
|
SCTMB211 |
Other Asian |
Active |
|
SCTMB212 |
Other North American |
Active |
|
SCTMB213 |
Northern European |
Active |
|
SCTMB214 |
Southern and East African |
Active |
|
SCTMB215 |
Latin, Central, and South American |
Active |
|
SCTMB216 |
West Central Asian and Middle Eastern |
Active |
|
SCTMB217 |
British Isles |
Active |
|
SCTMB218 |
Eastern European |
Active |
|
SCTMB219 |
North African |
Active |
|
SCTMB220 |
Southern European |
Active |
|
SCTMB221 |
Central and West African |
Active |
|
SCTMB222 |
Caribbean |
Active |
|
SCTMB223 |
Exposure meeting setting/location: Internet app - Grindr |
Active |
|
SCTMB224 |
Exposure meeting setting/location: Internet app - Facebook |
Active |
|
SCTMB225 |
Exposure meeting setting/location: Internet- other apps/sites |
Active |
|
SCTMB226 |
Previous treatment for infection |
Active |
|
SCTMB227 |
Exposure to sexually transmitted and blood borne infection |
Active |
|
SCTMB228 |
Sometimes uses a condom |
Active |
|
SCTMB229 |
Does not use a condom |
Active |
|
SCTMB230 |
Condom use unknown |
Active |
|
SCTMB231 |
Frequency of sexual contact with individual - once |
Active |
|
SCTMB232 |
Frequency of sexual contact with individual - 2 to 10 times |
Active |
|
SCTMB233 |
Frequency of sexual contact with individual - 10+ times |
Active |
|
SCTMB234 |
Frequency of sexual contact with individual - unknown |
Active |
|
SCTMB235 |
Type of community contact |
Active |
|
SCTMB236 |
Sexual exposure setting/location |
Active |
|
SCTMB237 |
Influenza A virus subtype H2N7 |
Active |
|
SCTMB238 |
Streptococcus agalactiae serotype non-typeable |
Active |
|
SCTMB239 |
Perianal ulcer |
Active |
|
SCTMB240 |
Rash, generalized |
Active |
|
SCTMB241 |
Serum, Acute |
Active |
|
SCTMB242 |
Serum, Convalescent |
Active |
|
SCTMB243 |
Spine |
Active |
|
SCTMB244 |
Contact with tall grass or wooded areas |
Active |
|
SCTMB245 |
Household contact with confirmed or suspected case |
Active |
|
SCTMB246 |
Occupational exposure |
Active |
|
SCTMB247 |
Recipient of pooled concentrates of factor VIII or IX |
Active |
|
SCTMB248 |
Safe injection program use |
Active |
|
SCTMB249 |
Cisgender |
Active |
|
SCTMB250 |
Park - municipal |
Active |
|
SCTMB251 |
Park - provinical/national |
Active |
|
SCTMB252 |
Previous Diagnosis-new to Manitoba |
Active |
|
SCTMB253 |
Erythema migrans-multiple episodes |
Active |
|
SCTMB254 |
Erythema migrans-single episode |
Active |
|
SCTMB255 |
Newborn prophylaxis for hepatitis B |
Active |
|
SCTMB256 |
Immunity - previous disease |
Active |
|
SCTMB257 |
Indeterminate - lab evidence |
Active |
|
SCTMB258 |
Partially immunized |
Active |
|
SCTMB259 |
Susceptible - lab evidence |
Active |
|
SCTMB260 |
Unimmunized |
Active |
|
SCTMB261 |
Health record/healthcare provider |
Active |
|
SCTMB262 |
Client/parent/guardian |
Active |
|
SCTMB263 |
Client/parent/guardian - official record |
Active |
|
SCTMB264 |
Fully immunized |
Active |
|
SCTMB265 |
Animal or animal waste contact |
Active |
|
SCTMB266 |
Handler of raw, bloody or undercooked meat, fish, or seafood |
Active |
|
SCTMB267 |
Deltoid: upper right |
Active |
|
SCTMB268 |
Deltoid: lower right |
Active |
|
SCTMB269 |
Deltoid: upper left |
Active |
|
SCTMB270 |
Deltoid: lower left |
Active |
|
SCTMB271 |
Syphilitic stillbirth |
Active |
|
SCTMB272 |
Old case - previously diagnosed/known in Manitoba |
Active |
|
SCTMB273 |
Radiographic evidence of syphilis in long bones |
Active |
|
SCTMB274 |
Reactive CSF VDRL |
Active |
|
SCTMB275 |
Reactive serology with 4x higher than mother (on same date) |
Active |
|
SCTMB276 |
Public health inspection |
Active |
|
SCTMB277 |
Environmental sampling |
Active |
|
SCTMB278 |
Food sampling |
Active |
|
SCTMB279 |
Facility closure |
Active |
|
SCTMB280 |
Laboratory testing for disease during first trimester |
Active |
|
SCTMB281 |
Laboratory testing for disease at 28-32 weeks gestation |
Active |
|
SCTMB282 |
Laboratory testing for disease at delivery |
Active |
|
SCTMB283 |
Laboratory testing - number of times tested during pregnancy (including delivery) |
Active |
|
SCTMB284 |
Maternal diagnosis date during pregnancy |
Active |
|
SCTMB285 |
Maternal history of STBBIs during pregnancy |
Active |
|
SCTMB286 |
Maternal incarceration during pregnancy |
Active |
|
SCTMB287 |
Maternal partner with untreated infection |
Active |
|
SCTMB288 |
Reinfection or relapse during pregnancy after appropriate therapy |
Active |
|
SCTMB289 |
Substance use during pregnancy |
Active |
|
SCTMB290 |
Substance use during pregnancy - crystal meth |
Active |
|
SCTMB291 |
Treatment for infection during pregnancy |
Active |
|
SCTMB292 |
Treatment for infection during pregnancy assessed as inadequate |
Active |
|
SCTMB293 |
Treatment - inadequate serologic response documented during pregnancy |
Active |
|
SCTMB294 |
Contact with someone with similar illness |
Active |
|
SCTMB295 |
Insect repellent use |
Active |
|
SCTMB296 |
Characteristic clinical late manifestations of syphilis |
Active |
|
SCTMB297 |
PCR positive |
Active |
|
SCTMB298 |
Reactive serology with rising titres |
Active |
|
SCTMB299 |
Sensitive Environment/Occupation |
Active |
|
SCTMB300 |
Latin American |
Active |
|
SCTMB301 |
COVID-19 mRNA Vaccine BNT162b2 Pfizer Canada ULC/BioNTech SE |
Active |
|
SCTMB302 |
COVID-19 mRNA Vaccine mRNA-1273 Moderna Therapeutics Inc. |
Active |
|
SCTMB303 |
Medical Exemption Program |
Active |
|
SCTMB304 |
Events - private/public |
Active |
|
SCTMB305 |
Animal care or supply |
Active |
|
SCTMB306 |
Conference |
Active |
|
SCTMB307 |
Funeral |
Active |
|
SCTMB308 |
Wedding |
Active |
|
SCTMB309 |
Banquet/Social |
Active |
|
SCTMB310 |
Concert |
Active |
|
SCTMB311 |
Religious Event |
Active |
|
SCTMB312 |
Sacred/Spiritual Event |
Active |
|
SCTMB313 |
Support programs for persons living with disabilities/day programs |
Active |
|
SCTMB314 |
Other workplace |
Active |
|
SCTMB315 |
Other public facility |
Active |
|
SCTMB316 |
Cultural Centre |
Active |
|
SCTMB317 |
Day camp/overnight camp |
Active |
|
SCTMB318 |
Recreational sporting event/tournament |
Active |
|
SCTMB319 |
Professional sporting event |
Active |
|
SCTMB320 |
Carpool |
Active |
|
SCTMB321 |
Public health nursing service |
Active |
|
SCTMB322 |
Escherichia coli serotype O Rough:HNM |
Inactive |
Replaced with SCT code 457124003 |
SCTMB323 |
Escherichia coli serotype O Undetermined:H11 |
Active |
|
SCTMB324 |
Escherichia coli serotype O136:H25 |
Active |
|
SCTMB325 |
Escherichia coli serotype O154:H8 |
Active |
|
SCTMB326 |
Escherichia coli serotype O156:H1 |
Active |
|
SCTMB327 |
Escherichia coli serotype O158:H21 |
Active |
|
SCTMB328 |
Escherichia coli serotype O23:H10 |
Active |
|
SCTMB329 |
Escherichia coli serotype O78:H19 |
Active |
|
SCTMB330 |
Escherichia coli serotype O8:H7 |
Active |
|
SCTMB331 |
Escherichia coli serotype O85:H2 |
Active |
|
SCTMB332 |
Escherichia coli serotype O87:H2 |
Active |
|
SCTMB333 |
Escherichia coli serotype O9:H19 |
Active |
|
SCTMB334 |
Salmonella species not Salmonella Typhimurium |
Active |
|
SCTMB335 |
Shiga toxin-producing gene(s) |
Active |
|
SCTMB336 |
Streptococcus agalactiae serotype Ib/IV |
Active |
|